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ARTICLE OPEN
Telomere length and human hippocampal neurogenesis
Alish B. Palmos1, Rodrigo R. R. Duarte1,2, Demelza M. Smeeth3, Erin C. Hedges3, Douglas F. Nixon 2, Sandrine Thuret 3,4 and
Timothy R. Powell 1,2
Short telomere length is a risk factor for age-related disease, but it is also associated with reduced hippocampal volumes, age-
related cognitive decline and psychiatric disorder risk. The current study explored whether telomere shortening might have an
influence on cognitive function and psychiatric disorder pathophysiology, via its hypothesised effects on adult hippocampal
neurogenesis. We modelled telomere shortening in human hippocampal progenitor cells in vitro using a serial passaging protocol
that mimics the end-replication problem. Serially passaged progenitors demonstrated shorter telomeres (P ≤ 0.05), and reduced
rates of cell proliferation (P ≤ 0.001), with no changes in the ability of cells to differentiate into neurons or glia. RNA-sequencing and
gene-set enrichment analyses revealed an effect of cell ageing on gene networks related to neurogenesis, telomere maintenance,
cell senescence and cytokine production. Downregulated transcripts in our model showed a significant overlap with genes
regulating cognitive function (P ≤ 1 × 10−5), and risk for schizophrenia (P ≤ 1 × 10−10) and bipolar disorder (P ≤ 0.005). Collectively,
our results suggest that telomere shortening could represent a mechanism that moderates the proliferative capacity of human
hippocampal progenitors, which may subsequently impact on human cognitive function and psychiatric disorder pathophysiology.
Neuropsychopharmacology (2020) 0:1–9; https://doi.org/10.1038/s41386-020-00863-w
INTRODUCTION
Patients with schizophrenia, bipolar disorder and major depressive
disorder, have an average life expectancy approximately a decade
lower than the rest of the population [1–3]. This statistic primarily
reflects the higher prevalence of comorbid age-related diseases,
including coronary artery disease, diabetes and dementia, which
contribute to early mortality [3, 4]. Epidemiological findings such
as these, have prompted researchers to consider whether faster
ageing represents a core component to the pathophysiology of
psychiatric disorders, or whether it represents the consequences
of unhealthy lifestyles and stressful experiences, more common
amongst those diagnosed with a psychiatric disorder [5, 6].
Telomere length is one biological marker which has been used
to study rates of cell ageing amongst psychiatric disorder patients
[7]. Telomeres are DNA repeat structures found at the ends of
chromosomes, which in humans, comprise of a six-nucleotide
repeat sequence (TTAGGG) [8]. Telomeres are vital for maintaining
chromosomal stability [9] and have been shown to regulate a cell's
ability to replicate via mitosis [10]. Telomere length gets shorter
with each somatic cell division due to the inability of DNA
polymerase to fully replicate the 3′ end of the new DNA strand
during DNA replication; a phenomenon known as the end-
replication problem [11]. Furthermore, telomerase activity [12],
oxidative stress [13], genetics [14] and specific environmental
factors, such as stress and exercise [15], moderate telomere length
and the rate at which it shortens. When a telomere reaches a
critically short length, the cell stops dividing and reaches a state of
cellular senescence, often referred to as the ‘Hayflick limit’ [16].
The Hayflick limit has been demonstrated in a variety of adult cell
types in vitro, including fibroblasts [10], endothelial cells [17] and
lymphocytes [18], whereby cells exhibit progressively shorter
telomeres over increasing passages (or ‘population doublings’), a
gradual reduction in their ability to proliferate, a reduced
propensity to undergo programmed cell death, and a maladaptive
proinflammatory phenotype [19]. The reduced replicative capacity
of ageing cells is hypothesised to contribute to age-related tissue-
level pathology in vivo; as old, damaged cells, can no longer be
replaced with new, healthy cells [20].
In the context of psychiatry, meta-analyses reveal that, in
general, psychiatric disorder patients exhibit shorter leukocyte
telomere lengths relative to unaffected individuals of equivalent
ages, which could contribute to the increased burden of age-
related disease [21–24]. In addition to shorter telomere lengths,
psychiatric disorder patients frequently exhibit neurological
differences such as smaller hippocampi [25–27], and some studies
have suggested a relationship between shortened telomere
length and psychiatric disorder neuropathology [28–31].
The hippocampus is a brain structure important in cognition
and mood regulation that is capable of adult neurogenesis due to
the retainment of neural progenitors in the dentate gyrus; a
specialised niche that allows progenitors to form new, functional
neurons [32]. Most cross-sectional studies [29, 33–35], though not
all [36–38], have reported positive associations between periph-
eral telomere length and hippocampal volume, or between
peripheral telomerase activity and hippocampal volume [39].
Recent longitudinal data also support this relationship,
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demonstrating that greater leukocyte telomere shortening in
elderly individuals is associated with a steeper loss in hippocampal
volume [40]. Intriguingly, there is also a positive relationship
between telomere length and cognitive performance [29, 31], and
it has been hypothesised that telomere length contributes to this
association by moderating the rate of adult neurogenesis [41]. This
hypothesis is supported by various lines of evidence. First,
chronological age and mood dysfunction is associated with both
shorter telomere length in hippocampal tissue, and reduced rates
of hippocampal neurogenesis [42–46]. Consequently, telomere
shortening in proliferating neural cell populations might be
driving tissue-level differences in telomere length observed in
the hippocampus. Second, reduced rates of hippocampal
neurogenesis correlate with poorer performance in the Morris
water maze task [47], and in visual pattern discrimination tasks
[48], indicative of cognitive dysfunction; as well as reduced swim
time in the forced-swim test, indicative of depression-like
behaviour [49]. Third, reductions in the expression of genes that
regulate telomere length in the adult hippocampus in conditional
knockout mouse models recapitulate age-related impairments to
hippocampal neurogenesis, cognitive performance and behaviour,
suggesting that telomere function is a key regulator of age-
related changes to neurogenesis and cognition [50, 51]. Despite
these insights, to-date, there have been no studies investigating
the impact of telomere shortening on human hippocampal
progenitor cells, nor its downstream relationship to cognition
and psychiatric disease. This is largely due to the inaccessibility
of the dentate gyrus; the fact that there are no validated
peripheral biomarkers or neuroimaging tools to assess rates of
hippocampal neurogenesis in vivo, in association with cognition
and psychiatric conditions; and methodological challenges, like
reliably immuno-staining post-mortem brain samples in large
numbers [52].
The current study employed a systematic, multidisciplinary
approach which aimed to model the effects of telomere
shortening on human hippocampal neurogenesis, and subse-
quently its relationship to cognition and psychiatric disorder risk.
First, we modelled telomere shortening using a serial passaging
protocol that recapitulates the end-replication problem, in a
human hippocampal progenitor cell line. We confirmed that
reductions in telomere length were associated with lower levels of
cell proliferation, without affecting the ability of cells to
differentiate into neurons or glia. Second, complementary RNA-
sequencing data revealed 3281 transcripts which change in
association with telomere shortening. Of these, the 1594 down-
regulated genes strongly overlap with genes implicated in
cognitive function and schizophrenia, and to a lesser extent
bipolar disorder. Our work suggests that in addition to the
established role of telomere length in age-related pathology, it
may also play a role in psychiatric disorder neuropathophysiology
via its effects on hippocampal progenitor cell proliferation.
MATERIALS AND METHODS
Human hippocampal progenitor cell line
An existing multipotent human foetal hippocampal progenitor cell
line, HPCOA07/03 (ReNeuron, UK), was used to model human
hippocampal neurogenesis in vitro, as used previously by our
team [53–56]. These cells proliferate in the presence of growth
factors, and upon their removal, differentiate into PROX-1 positive
neurons, and glia. For further details on the cell line and culture
conditions for proliferating and differentiating cells, see Supple-
mentary information, S1, S2.
Modelling telomere shortening via the ‘end replication problem’
As in other in vitro systems [17, 18, 57], we modelled telomere
shortening by serially passaging cells. Serial passaging allows cell
populations to double numerous times, and facilitates telomere
shortening resulting from the end-replication problem (the
incomplete synthesis of chromosome ends during DNA
replication).
Our experimental protocol utilised four cryovials corresponding
to four subcultures of cells (biological replicates), which were
revived in separate T25 flasks and grown in proliferating medium.
Once confluent, the cells were passaged onto a T75 flask under
the same conditions, see Supplementary information, S1. ‘Cells at
baseline’ in our model corresponded to those utilised at the start
of our study, which had undergone fewer cell divisions and
which have a lower passage number (P21). Subsets of cells were
then, either isolated and pelleted for DNA and RNA extraction
(telomere length assessment and RNA-sequencing); seeded onto
two 96-well plates for proliferation and differentiation assays
(immunocytochemistry); or seeded onto a new T75 flask for
subsequent serial passaging, see Fig. 1. Passaging occurred once
cells were 80–90% confluent (~48 h), as confirmed by cell count.
At each passage, cells were reseeded at a density of 2 × 106 cells/
T75 flask to ensure an approximately consistent number of
population doublings across biological replicates. ‘Serially pas-
saged cells’ in our model corresponded to a subset of P21 cells
that underwent eight subsequent passages (P29), where again we
isolated DNA and RNA, or submitted cells to a final proliferation or
differentiation assay, Fig. 1.
Proliferation and differentiation assays (immunocytochemistry)
To compare differences in cell marker levels between cells at
baseline and serially passaged cells, we performed immunocy-
tochemistry using an established 3-day proliferation protocol
performed on 96-well plates, where we assayed the proliferation
markers BrdU and Ki67, and the apoptosis marker caspase-3 (CC3).
We also assessed differentiation as part of a 7-day protocol, where
we assayed neuronal markers, doublecortin (DCX) and
microtubule-associated protein 2 (MAP-2), the astrocyte marker,
S100β and apoptotic marker, CC3. See Supplementary informa-
tion, S3–S5 for further details.
Fig. 1 Protocol summary. A summary of our in vitro protocol,
which considered telomere length, mRNA expression, cell markers
of proliferation, and cell markers of differentiation, in association
with cell passaging.
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Nucleic acid extraction
Approximately 50% of the cell suspension obtained during
passaging was pelleted and stored at −80 °C at the beginning
(passage 21; cells at baseline) and end of experiments (passage 29;
serially passaged cells). DNA and RNA were extracted using the
Qiagen AllPrep DNA/RNA/Protein Mini Kit (Qiagen, Hilden,
Germany), see Supplementary information, S6, for further details.
Telomere length measurements
Relative telomere length was quantified using DNA samples and a
modified version of the quantitative Polymerase Chain Reaction
protocol described by Cawthon [58], as used by our lab previously
[5, 7, 14, 29], see Supplementary information, S7, for further
details.
RNA-sequencing
Library preparation and RNA-sequencing was performed at The
Genomic Centre, King’s College London. Briefly, total RNA samples
were submitted to a DNAse treatment using the DNA-free™ DNA
Removal Kit (Invitrogen, California, USA). Subsequently, 300 ng of
total RNA from each sample was submitted for ribosomal RNA
depletion using the NEBNext rRNA Depletion kit (New England
Biolabs, Massachusetts, USA), and RNA-Seq libraries were con-
structed using the NEBNext Ultra II Directional RNA Library Prep Kit
for Illumina. The samples were sequenced in a HiSeq 4000 sequen-
cing system (Illumina). Raw reads were downloaded and
processed using a systematic approach, see Supplementary
information, S8. Differential expression analysis was performed
to compare cells at baseline versus serially passaged cells (N= 4
biological replicates per condition) using the Wald test in DESeq2,
controlling for biological replicates. Log2 fold-changes were
shrunk using apeglm [59], and the false discovery rate (FDR)
correction was used to control for multiple comparisons. Gene
expression differences were considered significant if PFDR < 0.05.
Gene ontology (GO) enrichment
To understand which biological mechanisms were being affected
in our cell model in association with telomere shortening, we
separately entered genes (PFDR < 0.05) showing an increase in
expression, and those showing a decrease in expression, into
FUMA [60]. The GENE2FUNC tool performs a gene-set enrichment
analysis, where gene sets were defined by The Molecular
Signatures Database. We included all transcripts surviving
DESeq2’s internal filtering criteria as our background list (i.e. all
genes expressed in the samples). Multiple testing correction was
performed using the FDR method, and GO terms were considered
significant if PFDR < 0.05.
Gene-set enrichment analysis
We tested for a genetic overlap between upregulated and
downregulated genes affected in our cell ageing model and
those implicated in major depressive disorder [61], bipolar
disorder [62], schizophrenia [63] and general cognitive function
[64], using MAGMA [65] and publicly available GWAS summary
statistics, see Supplementary Information, S9.
Foetal brain samples
We performed a complementary experiment using foetal brain
samples in order to clarify whether telomere shortening occurs in
the human brain during early development in accordance with
gestational age, and therefore, whether our cell model could also
be recapitulating a neurodevelopmental cell process. Brain tissue
was obtained frozen and had not been dissected into regions. Half
of the brain tissue from each individual foetus was homogenised
for subsequent genomic DNA extraction, which was performed by
standard phenol-chloroform procedures as described previously
[66]. Sample sex was determined via PCR amplification [66]. In
total, DNA was available from 37 females and 48 males (n= 85).
Gestational ages were estimated using foot and knee to heel
length measurements. Gestational ages ranged from 75–161 days,
with a mean gestational age of 107.96 (S.D.= 16.12). Telomere
length was quantified as above, and as described in Supplemen-
tary Information S7. The human embryonic and foetal material
was provided by the Joint MRC/Wellcome Human Developmental
Biology Resource (www.hdbr.org). Ethical approval for the HDBR
was granted by the Royal Free Hospital research ethics committee
under reference 18/NE/0290.
Statistical analyses
Differences in telomere length between the baseline condition
and serially passaged cells was determined using a two-tailed
independent-samples t-test. Similarly, differences in the expres-
sion of cell markers were determined using two-tailed indepen-
dent-samples t-tests, followed by a Bonferroni correction to
account for the total number of markers assayed in either the
proliferating or differentiating cell conditions. To test the effect of
gestational age on telomere length in the foetal brain, we ran a
linear regression with relative telomere length as the outcome
variable, sex as a covariate and gestational age (days) as the
independent variable. Data normality was confirmed using the
Shapiro–Wilk test. RNA-sequencing and downstream analyses
were performed as described above.
Figure generation
Figures were created using Prism7 (GraphPad, San Diego USA), the
EnhancedVolcano package in R [67] and BioRender (Toronto,
Canada).
RESULTS
(i) Hippocampal progenitor cells demonstrate telomere shortening
in response to serial passaging and the end-replication problem
We compared relative telomere length in cells at baseline (P21)
and in cells which had undergone serial passaging (P29). An
independent samples t-test confirmed shorter telomere length in
the serially passaged cells relative to cells at baseline (t(6) = 3.542,
P= 0.012), Fig. 2.
To complement this finding, we confirmed that telomere
shortening was likely being driven by the end-replication problem,
as opposed to changes to the telomerase enzyme (another critical
Fig. 2 Telomeres are shorter in serially passaged hippocampal
progenitor cells. This bar chart shows the relative telomere length
in cells at baseline (P21) and serially passaged cells (P29). There is a
significant reduction in telomere length in serially passaged cells
relative to cells at baseline. Group differences were detected using
an independent samples t-test. Significant differences were con-
sidered when P ≤ 0.05, indicated by *.
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telomere regulator) during passaging. hTERT codes for the
catalytic subunit of the telomerase enzyme and is tightly
controlled, and closely associated with enzyme activity [68]. We
performed a quantitative PCR to assess differences in the
expression of telomerase reverse transcriptase (hTERT) in cells at
baseline and serially passaged cells, and found consistently low
levels of hTERT expression (relative to the reference gene,
Vimentin), which did not differ between groups (t(6)= 1.151,
P= 0.294); see Supplementary information, S10.
(ii) Serially passaged hippocampal progenitor cells exhibit
decreased cell proliferation
Cells demonstrated a significant reduction in proliferation in
association with telomere shortening, Fig. 3. Serially passaged cells
exhibited significantly lower levels of proliferation relative to
baseline cells, as marked using BrdU staining (two-sample t-test,
t(6)= 6.663, P= 0.0006), a difference which remained significant
after correcting for the number of cell markers tested (P ≤ 0.05).
This difference was also supported by quantification of the
proliferation marker Ki67 (two-sample t-test, t(6) = 2.959, P=
0.025). We also observed a lower percentage of serially passaged
cells stained with CC3 (indicative of lower rates of cell
death), relative to cells at baseline (two-sample t-test, t(6)=
2.481, P= 0.047), however this effect did not survive multiple
testing correction (P > 0.05); representative CC3 staining is shown
in Fig. 4.
(iii) Serially passaged hippocampal progenitor cells do not show
differences in their rate of cell differentiation
We observed no differences (P > 0.05) in markers pertaining to
glial cells (S100β), cell death (CC3) or more mature neurons (MAP-
2), between cells at baseline and serially passaged cells. There was
a small increase in the number of doublecortin-positive neurons
observed in serially passaged cells (two-sample t(6)= 3.097, P=
0.021), though this difference did not survive multiple testing
correction (P > 0.05), Fig. 4.
(iv) Cell ageing is associated with vast transcriptional changes
related to neurogenic processes, cellular senescence and
inflammation
We identified 3281 transcripts which were differentially expressed
in serially passaged cells relative to cells at baseline (PFDR < 0.05),
Fig. 5a. We found that 1687 genes were upregulated in serially
passaged cells, and these genes were associated with cell
adhesion. Enrichment amongst canonical pathways revealed an
over-representation of genes related to inflammation and
cytokine signalling, Fig. 5b. In agreement with previous work
relating to the senescence associated secretory phenotype,
amongst the upregulated transcripts we observed increased
expression of the cytokine regulator, Nuclear Factor Kappa B
(NFKB1) and increased interleukin-6 (IL6) levels (PFDR < 0.05) [19].
See Supplementary Datasets for full results.
1594 genes were also downregulated in serially passaged cells.
These genes were broadly associated with neurogenesis and
nervous system development. Furthermore, enrichment amongst
canonical pathways revealed an over-representation of genes
related to telomeres, and cell senescence, Fig. 5c. Note that the
downregulated gene expression changes were also enriched for
genes affecting cell proliferation (GO_REGULATION_OF_CELL_PO-
PULATION_PROLIFERATION, adj P= 0.00244125; see Supplemen-
tary dataset), which supports our cell staining data.
(v) Genes downregulated in association with cell ageing overlap
with those implicated in cognitive performance, schizophrenia
and bipolar disorder risk
We found a significant overlap between genes which were
downregulated in serially passaged cells (PFDR < 0.05) and those
implicated in: schizophrenia (β= 0.207, SE= 0.032, P= 5.105 ×
10−11); bipolar disorder (β= 0.071, SE= 0.027, P= 0.005); and
general cognitive function (β= 0.138, SE= 0.037, P= 1.057 ×
10−5), based on GWAS results, Fig. 5d.
To ensure this result was not being inflated by the relatively
large size of our gene set (n= 1594), or by an overrepresentation
Fig. 3 Proliferation rates are lower in serially passaged hippocampal progenitor cells. Bar charts (top) show the percentage of BrdU (a) and
Ki67 (b) -positive cells relative to the percentage of DAPI stained nuclei (y-axis), in cells at baseline and serially passaged cells (x-axis). Each
datapoint represents one biological replicate (N= 4). * represents an uncorrected P ≤ 0.05, and *** represents an uncorrected P ≤ 0.001. Each
of the images (below) are representative of a field of immuno-stained cells, taken using a ×10 objective with the CellInsight High Content
Screening Platform. Each composite image includes the nuclear marker DAPI in blue. Scale bar = 100 μm.
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of genes related to tissue type, we performed a sensitivity analysis.
From the transcripts surpassing our multiple testing threshold, we
selected 500 which exhibited the highest fold change. In addition,
when mapping SNPs to genes, we removed any genes which were
not expressed in our cell line from the genomic annotation. When
repeating gene-set enrichment analysis, we confirmed that
downregulated transcripts remained significantly associated with
each trait (P ≤ 0.01). We found no significant overlap between
downregulated genes and those implicated in major depressive
disorder, nor between upregulated genes and any of our traits.
(vi) Telomere shortening may not occur during early
neurodevelopment
Previous evidence suggests that telomere shortening and reduced
rates of hippocampal neurogenesis are specific to the adult brain
[42–44], but schizophrenia risk and cognitive function are also
known to be affected by prenatal neurodevelopmental factors
[69]. We performed a complementary experiment in order to
clarify whether telomere shortening occurs in the human brain
during early development in accordance with gestational age, and
therefore, whether our cell model could also be recapitulating a
neurodevelopmental cell process. To determine whether telomere
shortening occurs in the developing brain, we assessed telomere
length in foetal brain samples collected from various post-
conception days (75–161 days), which is a measure that positively
correlates with the number of cell divisions [70]. We did not find a
significant correlation between telomere length and post-
conception days (β=−0.003 [95% CI: −0.328 to 0.322], P=
0.985), nor an effect of sex (β=−0.001 [−0.011 to 0.009], P=
0.887), see Supplementary information, S11. This suggests that the
effect we observe in our study, is unlikely to occur in early
neurodevelopment, further supporting the specificity of this
process to the postnatal brain.
DISCUSSION
Our study used serial passaging, an established method for
modelling telomere shortening via the end replication problem, in
human hippocampal progenitor cells. Serially passaged cells
demonstrated reduced rates of cell proliferation, as determined
by BrdU and Ki67 immunostaining. Telomere shortening was
further accompanied by changes to 3281 transcripts, whereby
downregulated genes overlapped with those implicated in
cognition, schizophrenia and bipolar disorder.
The findings presented here support previous research per-
formed in other cell model systems that reveal an intricate
relationship between telomere length and cell replicative capacity
related to the end-replication problem [17, 18, 57]. Our gene
expression data further demonstrates an enrichment of transcript
changes related to cell senescence, the senescence associated
secretory phenotype, and interleukin-6 signalling. This is in
agreement with previous research [19], and validates that our
model is capturing meaningful biological changes related to
telomere shortening and cell ageing. It also suggests that the
decreased proliferation (marked by BrdU) and the nominally
decreased cell death (marked by CC3; uncorrected P < 0.05) we
observed in serially passaged progenitors, likely relates to early
signs of cell senescence, i.e. a reduced number of new, healthy
cells, and an accumulation of mitotically old, unhealthy cells that
instead of apoptosing, demonstrate a proinflammatory phenotype.
In the context of neurogenesis, our findings extend prior work
in animals and post-mortem brain which have shown a significant
decline in markers of cell proliferation in the hippocampus in
association with age [71, 72], by raising the possibility that
telomere shortening is one potentially important age-related
cellular mechanism. In contrast to some work [43, 51], we did not
observe a robust effect of telomere shortening on rates of
neuronal differentiation, as marked by doublecortin and MAP-2 in
our cell staining data. However, amongst proliferating cells there
was a strong downregulation of doublecortin at the transcript
level in association with telomere shortening (Fig. 5a), which
might suggest that there are very early, transient reductions in the
rates of differentiation, which were not observable after the 7-day
differentiation protocol used in our model.
Genetic and association studies have inferred a causal relation-
ship between telomere length and cognition [31], but no study
Fig. 4 There are no differences in the rates of cell differentiation in serially passaged cells. The bar charts (right) show the percentage of
MAP-2 (a), CC3 (b), S100β (c) and DCX (d) -positive cells relative to the percentage of DAPI stained nuclei (y-axis), in cells at baseline and serially
passaged cells (x-axis). Each datapoint represents one biological replicate (N= 4). * represents an uncorrected P ≤ 0.05. Each of the images
(left) are representative of a field of immuno-stained cells, taken using a ×10 objective with the CellInsight High Content Screening Platform.
Each composite image includes the nuclear marker DAPI in blue. Scale bar = 100 μm.
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to-date, has demonstrated a cellular mechanism. Our work supports
these findings and demonstrates that telomere shortening is
associated with reduced hippocampal progenitor cell proliferation
alongside changes to the expression of genes regulating general
cognitive function. Our cell model and the gene-set enrichment
results raise the possibility of a relationship between telomere
shortening in human hippocampal progenitors and schizophrenia
and bipolar disorder risk. Both schizophrenia and bipolar disorder
share a common aetiology [73], and patients frequently exhibit
smaller hippocampal volumes [25–27] and general cognitive
deficits relating to attention, working memory, verbal learning
and memory and executive functions [74]. In the context of our
results, it is possible that telomere-induced reductions in hippo-
campal neurogenesis represent one mechanism that contributes to
cognitive dysfunction amongst these patients. This notion is also
supported by a study using mice, which demonstrates that a
maternal infection results in offspring with schizophrenia-like
behaviours, reduced rates of adult hippocampal neurogenesis,
and neural progenitors with both shorter telomere length and
reduced telomerase activity [75]. Interestingly, an environmental
intervention (increased exercise) was able to normalise both
abnormal cell phenotypes and behaviour in this model [75].
Our results add to the work of others (e.g. [75, 76]), and
collectively, they raise the possibility that environmental factors
with the potential to prevent premature telomere shortening may
also have positive influences on hippocampal neurogenesis and
cognitive function. Intriguingly, environmental interventions
shown to reduce the rate of cognitive ageing [77], including
exercise and energy restriction, have positive effects on both
peripheral telomere length in humans [15, 78, 79] and hippo-
campal neurogenesis in animal models [80, 81]. Furthermore, diets
rich in omega-3 fatty acids and antioxidants, have been associated
with both increased rates of hippocampal neurogenesis and
longer telomeres [32, 82, 83], as have some drugs, such as
resveratrol and lithium [14, 84–86]. This warrants further study in
order to determine whether environmental, dietary and pharma-
cological interventions could be useful in systematically targeting
premature cell ageing and reduced hippocampal neurogenesis.
Despite the promising evidence shown here, there are a
number of limitations to our study which should be acknowl-
edged. First, we are measuring changes to telomere length and its
effect on hippocampal neurogenesis using a cell model system
acquired from a single donor. It is possible that individuals from
different genetic backgrounds respond differently to the effects of
telomere shortening [14], and as such, future work utilising
induced pluripotent stem cell models from a range of donors
would be beneficial in validating and extending our work. In
addition, our in vitro model may lack construct validity due to the
absence of mature cells and established intercellular networks,
which are known to interact with progenitor cells and affect their
development [87]. Second, although our cell model demonstrated
telomere shortening and signs of cellular senescence, the effect
was modest, with some serially passaged cells continuing to
proliferate [10]. It is likely that a longer culture protocol will
provide greater insights into the progressive and longer-term
consequences of telomere shortening in hippocampal cells, and
this is an important future consideration. Third, the cell model
attempts to investigate the relationship between telomere short-
ening and adult hippocampal neurogenesis, in order to better
understand age-related changes to the brain. However, alongside
changes in telomere length, there may also be independent
changes to the cell (e.g. the epigenetic landscape [88]), so future
Fig. 5 Differentially expressed genes in serially passaged cells relative to cells at baseline, and gene sets implicated in cell ageing. a A
volcano plot summarising the RNA-sequencing results, where log2(Fold change) is shown on the x-axis, and the strength of the association
given by −Log10(P), is shown on the y-axis. b Examples of gene sets which significantly overlap with the upregulated genes in our cell model.
All gene sets represent those which surpassed a false discovery rate correction, PFDR < 0.05, in our enrichment analysis, as marked by the
dashed line. c Examples of gene sets which significantly overlap with the downregulated genes in our cell model. d A bar plot showing the
genetic overlap between various traits as assayed by GWAS (y-axis) and genes either upregulated or downregulated in association with cell
ageing. The strength of the association is shown on the y-axis (−log(p)). The dashed line represents the threshold of significance (corrected for
the number of tests).
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work will also be needed to further differentiate the causative
effects of telomere shortening (e.g. via TERT knockout), from other
age-related cell changes. Furthermore, our model makes use of
foetal-derived neural progenitors, which although studies suggest
do recapitulate the functions of adult neural stem cells, they may
not do so entirely [89]. Moreover, our work in foetal brain indicates
that despite the importance of early neurodevelopmental factors
in the aetiology of schizophrenia [69], telomere shortening does
not appear to occur during early brain development. Conse-
quently, further work will be needed to confirm at what stages in
postnatal life telomere shortening impacts on hippocampal
neurogenesis and becomes important in the pathophysiology of
psychiatric disease.
This work extends our understanding of the age-related molecular
mechanisms influencing hippocampal neurogenesis, and provides
support that telomere shortening may be an important process
associated with psychiatric disorders and cognitive function. It also
raises the possibility that there is a multisystemic relationship, in
which telomere shortening contributes not only to the heightened
rates of age-related disease amongst psychiatric disorder patients,
but its putative effects on hippocampal neurogenesis suggest it
could also represent a mechanism important in the pathophysiology
of psychiatric disorders themselves. Future work should consider
whether leukocyte telomere length could act as a useful peripheral
biomarker to estimate changes in the rates of hippocampal
neurogenesis in vivo, and whether environmental interventions
could be used to simultaneously prevent premature telomere
shortening and promote hippocampal progenitor proliferation, as
we age.
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